King Pharmaceuticals KG Program Services — Underwriting Income Loss Net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:UnderwritingIncomeLossNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's program services — underwriting income loss net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's program services — underwriting income loss net?
- King Pharmaceuticals (KG) reported program services — underwriting income loss net of $1.61M in Q1 2026.
- How has King Pharmaceuticals's program services — underwriting income loss net changed year-over-year?
- King Pharmaceuticals's program services — underwriting income loss net increased by 584.3% year-over-year, from $235K to $1.61M.
- What does program services — underwriting income loss net mean?
- The net profit or loss resulting from insurance underwriting activities after accounting for premiums, losses, and acquisition expenses. It is the primary measure of the segment's core insurance profitability.